Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triamcinolone acetonide + isopropyl alcohol + povidone-iodine
- Development stage
- Unknown
- Lead developer
- Rx Pharma-pack
- Modality
- Small Molecules
- Administration
- Intramuscular, Topical
01
Overview
**Triamcinolone acetonide + isopropyl alcohol + povidone-iodine** refers to a sterile procedure kit marketed as **P-CARE**, not a single co-formulated molecular entity. The kit combines **triamcinolone acetonide injectable suspension** as the therapeutic corticosteroid component with **isopropyl alcohol 70%** and **povidone-iodine** as topical antiseptic skin-preparation agents used immediately before injection. The pharmacologically active treatment component is triamcinolone acetonide, a **synthetic corticosteroid small molecule** that functions primarily as a **glucocorticoid receptor agonist** to suppress inflammatory and immune signaling. The alcohol and povidone-iodine components are included to reduce skin microbial burden at the injection site rather than to provide systemic therapeutic activity. In practice, this product is best understood as a branded injection-preparation kit built around KENALOG triamcinolone injection for corticosteroid administration procedures.
- Brand names
- P-CAREP-CARE K40P-CARE K80P-CARE K40GP-CARE K80G
- Other names
- triamcinolone acetonide + isopropyl alcohol + povidone-iodine
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on triamcinolone acetonide + isopropyl alcohol + povidone-iodine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triamcinolone acetonide + isopropyl alcohol + povidone-iodine.